NCT04630444View on ClinicalTrials.gov

Riluzole Effects on Hippocampus Biomarkers

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

March 16, 2017

Primary Completion Date

March 16, 2019

Study Completion Date

March 16, 2019

Conditions
Posttraumatic Stress Disorder
Interventions
DRUG

Riluzole

30 PTSD patients with riluzole 100 mg daily (50 mg bid).

Trial Locations (1)

02478

McLean Hospital, Belmont

Sponsors
All Listed Sponsors
collaborator

Brain & Behavior Research Foundation

OTHER

lead

Mclean Hospital

OTHER